Replies to post #23478 on Endonovo Therapeutics Inc (ENDV)

[sello]

That is good news for the sector. It seems Endonovo's target of treating critical limb ischemia goes much deeper than simply addressing the wounds created as a result of the disease. I don't see a conflict here, this is a good sign that the FDA is beginning to recognize the power of this and similar therapies. IMO

http://www.otcmarkets.com/stock/ENDV/news/Endonovo-Evaluating-Therapeutic-Potential-of-Non-Invasive-Electroceutical-Device-for-Treatment-of-Critical-Limb-Ischemia?id=158065&b=y

Endonovo has projected to have results from their CLI pretrial study in this quarter according to SeeThruEquity.